BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bal N, Yildirim S, Nursal TZ, Bolat F, Kayaselçuk F. Association of ezrin expression in intestinal and diffuse gastric carcinoma with clinicopathological parameters and tumor type. World J Gastroenterol 2007; 13(27): 3726-3729 [PMID: 17659733 DOI: 10.3748/wjg.v13.i27.3726]
URL: https://www.wjgnet.com/1007-9327/full/v13/i27/3726.htm
Number Citing Articles
1
Yun Kyung Kang, Seong Woo Hong, Hyucksang Lee, Woo Ho Kim. Prognostic implications of ezrin expression in human hepatocellular carcinomaMolecular Carcinogenesis 2010; 49(9): 798 doi: 10.1002/mc.20653
2
Barbara Chifenti, Mariangela Morelli, Michele Zavaglia, Domenico A. Coviello, Silvana Guerneri, Annalisa Santucci, Alessandro Paffetti, Massimo Masetti, Maria Teresa Locci, Gloria Bertacca, Alessandra Capodanno, Paola Collecchi, Daniela Campani, Franco Mosca, Generoso Bevilacqua, Andrea O. Cavazzana. Establishment and Characterization of 4 New Human Pancreatic Cancer Cell LinesPancreas 2009; 38(2): 184 doi: 10.1097/MPA.0b013e31818c746a
3
Daiki Okamura, Masayuki Ohtsuka, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Atsushi Kato, Masaru Miyazaki. Ezrin expression is associated with hepatocellular carcinoma possibly derived from progenitor cells and early recurrence after surgical resectionModern Pathology 2008; 21(7): 847 doi: 10.1038/modpathol.2008.59
4
Maria Fernanda Lopes Carvalho, Carolina Santana Calicchio, Bruna Oliveira de Almeida, Livia Bassani Lins de Miranda, Jean Carlos Lipreri da Silva, Keli Lima, João Agostinho Machado-Neto. Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cellsClinics 2024; 79: 100422 doi: 10.1016/j.clinsp.2024.100422
5
Walid S.H. Elsayed, Ola A. Harb, Nashwa Nawar, Heba F. Taha, Ahmed M. Abdou. Combined Ezrin overexpression and E-cadherin downregulation as predictors of invasiveness, higher incidence of metastases, progression and poor prognosis in patients with cervical cancerEgyptian Journal of Pathology 2018; 38(1): 35 doi: 10.1097/01.XEJ.0000534715.52780.a4
6
Kotoku Kawaguchi, Shinji Asano. Pathophysiological Roles of Actin-Binding Scaffold Protein, EzrinInternational Journal of Molecular Sciences 2022; 23(6): 3246 doi: 10.3390/ijms23063246
7
Marcelo Patara, Erika Maria Monteiro Santos, Renata de Almeida Coudry, Fernando Augusto Soares, Fábio Oliveira Ferreira, Benedito Mauro Rossi. Ezrin Expression as a Prognostic Marker in Colorectal AdenocarcinomaPathology & Oncology Research 2011; 17(4): 827 doi: 10.1007/s12253-011-9389-4
8
Jingchun Jin, Tiefeng Jin, Meiling Quan, Yingshi Piao, Zhenhua Lin. Ezrin overexpression predicts the poor prognosis of gastric adenocarcinomaDiagnostic Pathology 2012; 7(1) doi: 10.1186/1746-1596-7-135
9
Yazhou Cui, Tianliang Li, Denglu Zhang, Jinxiang Han. Expression of Ezrin and Phosphorylated Ezrin (pEzrin) in Pancreatic Ductal AdenocarcinomaCancer Investigation 2010; 28(3): 242 doi: 10.3109/07357900903124498
10
Zhe Wang, Mao-Lin He, Jin-Min Zhao, Hai-Hui Qing, Yang Wu. Meta-analysis of Associations of the Ezrin Gene with Human Osteosarcoma Response to Chemotherapy and PrognosisAsian Pacific Journal of Cancer Prevention 2013; 14(5): 2753 doi: 10.7314/APJCP.2013.14.5.2753
11
Li Li, Yuan-Yu Wang, Zhong-Sheng Zhao, Jie Ma. Ezrin is Associated with Gastric Cancer Progression and PrognosisPathology & Oncology Research 2011; 17(4): 909 doi: 10.1007/s12253-011-9402-y
12
Expression of Ezrin in Human Embryonic, Fetal, and Normal Adult TissuesJournal of Histochemistry & Cytochemistry 2011; 59(11): 1001 doi: 10.1369/0022155411418661
13
Feng Liang, Yangxin Wang, Ligen Shi, Jianmin Zhang. Association of Ezrin expression with the progression and prognosis of gastrointestinal cancer: a meta-analysisOncotarget 2017; 8(54): 93186 doi: 10.18632/oncotarget.21473
14
Afrodite Athanasopoulou, Panagiotis Aroukatos, Dimitrios Nakas, Maria Repanti, Helen Papadaki, Vasiliki Bravou. Decreased ezrin and paxillin expression in human urothelial bladder tumors correlate with tumor progressionUrologic Oncology: Seminars and Original Investigations 2013; 31(6): 836 doi: 10.1016/j.urolonc.2011.07.003
15
Xiao-Qin Zhang, Guo-Ping Chen, Tao Wu, Jian-Ping Yan, Jian-Ying Zhou. Expression and Clinical Significance of Ezrin in Non–Small-Cell Lung CancerClinical Lung Cancer 2012; 13(3): 196 doi: 10.1016/j.cllc.2011.04.002
16
Bulent Cetin, Ipek Isık Gonul, Suleyman Buyukberber, Barıs Afsar, Ozge Gumusay, Efnan Algın, Nedim Turan, Ahmet Ozet, Mustafa Benekli, Ugur Coskun. The impact of immunohistochemical staining with ezrin-carbonic anhydrase IX and neuropilin-2 on prognosis in patients with metastatic renal cell cancer receiving tyrosine kinase inhibitorsTumor Biology 2015; 36(11): 8471 doi: 10.1007/s13277-015-3589-6
17
TARO TOBO, MINAKO HIRAHASHI, TAKASHI YAO, SHINICHI AISHIMA, YOSHINAO ODA. Ezrin expression and its phosphorylation in gastric carcinoma with lymphoid stroma and Epstein-Barr virus infectionMolecular and Clinical Oncology 2013; 1(2): 220 doi: 10.3892/mco.2012.56
18
Jean Carlos Lipreri da Silva, Hugo Passos Vicari, João Agostinho Machado-Neto. Perspectives for Targeting Ezrin in Cancer Development and ProgressionFuture Pharmacology 2023; 3(1): 61 doi: 10.3390/futurepharmacol3010005